Pulmonx Total Current Assets 2019-2024 | LUNG

Pulmonx total current assets from 2019 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Pulmonx Annual Total Current Assets
(Millions of US $)
2023 $150
2022 $169
2021 $208
2020 $250
2019 $41
2018 $11
Pulmonx Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $146
2024-03-31 $148
2023-12-31 $150
2023-09-30 $147
2023-06-30 $164
2023-03-31 $181
2022-12-31 $169
2022-09-30 $183
2022-06-30 $193
2022-03-31 $201
2021-12-31 $208
2021-09-30 $228
2021-06-30 $233
2021-03-31 $239
2020-12-31 $250
2020-09-30 $56
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2018-12-31 $11
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.329B $0.069B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $40.428B 21.75
Tempus AI (TEM) United States $7.918B 0.00
Inspire Medical Systems (INSP) United States $6.215B 1157.72
Axonics (AXNX) United States $3.513B 0.00
Hims & Hers Health (HIMS) United States $3.503B 203.88
10x Genomics (TXG) United States $2.660B 0.00
Enovis (ENOV) United States $2.437B 17.67
Azenta (AZTA) United States $2.413B 137.03
Privia Health (PRVA) United States $2.280B 158.92
IRhythm Technologies (IRTC) United States $2.219B 0.00
Omnicell (OMCL) United States $1.968B 64.82
Clover Health Investments (CLOV) United States $1.492B 0.00
Schrodinger (SDGR) United States $1.436B 0.00
Phreesia (PHR) United States $1.389B 0.00
Standard BioTools (LAB) United States $0.753B 0.00
Fulgent Genetics (FLGT) United States $0.694B 0.00
Definitive Healthcare (DH) United States $0.538B 456.00
Health Catalyst (HCAT) United States $0.529B 0.00
Butterfly Network (BFLY) United States $0.406B 0.00
Talkspace (TALK) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.286B 0.00
TruBridge (TBRG) United States $0.183B 13.44
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.147B 0.00
Augmedix (AUGX) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
SHL Telemedicine (SHLT) Israel $0.055B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
111 (YI) China $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.036B 0.00
Outset Medical (OM) United States $0.034B 0.00
MSP Recovery (LIFW) United States $0.025B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00